Select topics include:
- Evolution of Artificial Intelligence (AI) technologies and the impact on toxicologic pathology.
- Current approaches to carcinogenicity testing.
- Predicting drug-drug interactions.
- Current understanding of idiosyncratic drug reaction.
- Assessing cardiovascular risks beyond QT interval.
- Use of 3D cell cultures in toxicology and ADME.
- Development of small molecule-antibody complexes.
- Differentiating adverse from non-adverse findings in nonclinical studies.
Current Topics in Nonclinical Drug Development: Volume 2 will aid toxicologists, toxicologic pathologists, consultants, regulators, study directors, and nonclinical scientists dealing with day-to-day issues encountered in drug development and assist in formulating strategies for resolution of these issues. In addition, the book will be a valuable reference for academicians and graduate students pursuing research related to nonclinical drug development.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.